Who owns Tempest Therapeutics Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Tempest Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Tempest Therapeutics stock

Who bought or sold Tempest Therapeutics Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 163k $1.7M 21% Sep 2025
 View chart
Geode Capital Management 41k $422k 18% Sep 2025
 View chart
BlackRock 39k $402k 0% Sep 2025
 View chart
FMR 33k $332k 0% Sep 2025
 View chart
Belvedere Trading 30k $312k 29% Sep 2025
 View chart
DRW Holdings 19k $194k 100% Sep 2025
 View chart
UBS Group 11k $117k 1% Sep 2025
 View chart
Morgan Stanley 2.1k $14k 100% Jun 2025
 View chart
Advisor Group Holdings 1.7k $17k -10% Sep 2025
 View chart
Atlantic Trust 460.00 $4.7k 77% Sep 2025
 View chart
Federation des caisses Desjardins du Quebec 292.00 $3.0k 0% Sep 2025
 View chart
SBI Securities 56.00 $575.999200 0% Sep 2025
 View chart
Parallel Advisors 18.00 $185.000400 0% Sep 2025
 View chart
Wells Fargo & Company 3.00 $30.999900 100% Sep 2025
 View chart
Bnp Paribas Arbitrage, Snc 3.00 $30.999900 0% Sep 2025
 View chart

Who sold out of Tempest Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Sabby Management Jun 2025 277k $1.9M
Tang Capital Management Jun 2025 139k $945k
Susquehanna International Jun 2025 26k $175k
National Bank Of Canada /fi/ Jun 2025 1.5k $10k
Raymond James Financial Jun 2025 234.00 $1.6k